Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms.

This over-24 years study underlines an increasing withdrawal from protocol and a dichotomization of participants' age. We also show a strong concordance between symptoms perceived by the neurologist or by the patient, and the subsequent positivity of the predictive molecular test.